DK1561460T3 - Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme - Google Patents
Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det sammeInfo
- Publication number
- DK1561460T3 DK1561460T3 DK03765124T DK03765124T DK1561460T3 DK 1561460 T3 DK1561460 T3 DK 1561460T3 DK 03765124 T DK03765124 T DK 03765124T DK 03765124 T DK03765124 T DK 03765124T DK 1561460 T3 DK1561460 T3 DK 1561460T3
- Authority
- DK
- Denmark
- Prior art keywords
- nanoparticles
- active ingredients
- administration
- preparing
- particles
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 5
- 239000004480 active ingredient Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 abstract 1
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 229920002581 Glucomannan Polymers 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 229940046240 glucomannan Drugs 0.000 abstract 1
- 235000019832 sodium triphosphate Nutrition 0.000 abstract 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical group [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200201694A ES2221530B1 (es) | 2002-07-19 | 2002-07-19 | Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen. |
| PCT/ES2003/000372 WO2004009060A1 (es) | 2002-07-19 | 2003-07-16 | Nanopartículas para la administración de ingredientes activos, procedimiento para la elaboración de dichas partículas y composición que las contienen. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1561460T3 true DK1561460T3 (da) | 2007-04-30 |
Family
ID=30470576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03765124T DK1561460T3 (da) | 2002-07-19 | 2003-07-16 | Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060134785A1 (pt) |
| EP (1) | EP1561460B1 (pt) |
| AT (1) | ATE348602T1 (pt) |
| CA (1) | CA2492995A1 (pt) |
| CY (1) | CY1106361T1 (pt) |
| DE (1) | DE60310605T2 (pt) |
| DK (1) | DK1561460T3 (pt) |
| ES (2) | ES2221530B1 (pt) |
| PT (1) | PT1561460E (pt) |
| SI (1) | SI1561460T1 (pt) |
| WO (1) | WO2004009060A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2226567B1 (es) * | 2003-06-20 | 2006-07-01 | Universidad De Santiago De Compostela | Nanoparticulas de acido hialuronico. |
| ES2246694B1 (es) | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Nanoparticulas pegiladas. |
| ES2246695B1 (es) | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico. |
| WO2007036946A1 (en) * | 2005-09-28 | 2007-04-05 | Padma Venkitachalam Devarajan | Compositions for enhanced absorption of biologically active agents |
| EP1774971A1 (en) * | 2005-10-14 | 2007-04-18 | Advanced in Vitro Cell Technologies, S.L. | Chitosan and heparin nanoparticles |
| WO2007149868A2 (en) * | 2006-06-20 | 2007-12-27 | The Regents Of The University Of California | Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| US9173852B2 (en) * | 2008-04-08 | 2015-11-03 | Tian Si Polymer Materials Technology Development Co. | Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof |
| JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
| JP5675798B2 (ja) * | 2009-07-09 | 2015-02-25 | ポリマーズ シーアールシー リミテッドＰｏｌｙｍｅｒｓ ＣＲＣ Ｌｔｄ． | バイオポリマーハイブリッドゲルデポー送達システム |
| DE102009048553A1 (de) | 2009-09-29 | 2011-03-31 | Carl Zeiss Smt Gmbh | Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren |
| US8802076B2 (en) * | 2010-10-04 | 2014-08-12 | Duke University | Compositions and methods for modulating an immune response |
| JP5903250B2 (ja) * | 2011-11-16 | 2016-04-13 | 清水化学株式会社 | 徐放性組成物 |
| KR101372834B1 (ko) * | 2011-12-12 | 2014-03-14 | 전북대학교산학협력단 | 하이드로겔 버블 및 이의 제조방법 |
| US9114091B2 (en) * | 2013-07-05 | 2015-08-25 | Shimizu Chemical Corporation | Sustained release solid dosage preparations |
| CN107970228A (zh) * | 2017-11-02 | 2018-05-01 | 天津大学 | 一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法 |
| CN111420067B (zh) * | 2020-03-09 | 2021-08-27 | 西南交通大学 | 一种复合微球纳米载体及其制备方法和应用 |
| WO2021209493A2 (en) * | 2020-04-15 | 2021-10-21 | Solyplus Gmbh | Means and methods of preventing and treating infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688422A1 (fr) * | 1992-03-11 | 1993-09-17 | Coletica | Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant. |
| ES2114502B1 (es) * | 1996-07-29 | 1999-07-01 | Univ Santiago Compostela | Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas. |
-
2002
- 2002-07-19 ES ES200201694A patent/ES2221530B1/es not_active Expired - Fee Related
-
2003
- 2003-07-16 WO PCT/ES2003/000372 patent/WO2004009060A1/es active IP Right Grant
- 2003-07-16 DK DK03765124T patent/DK1561460T3/da active
- 2003-07-16 CA CA002492995A patent/CA2492995A1/en not_active Abandoned
- 2003-07-16 AT AT03765124T patent/ATE348602T1/de not_active IP Right Cessation
- 2003-07-16 EP EP03765124A patent/EP1561460B1/en not_active Expired - Lifetime
- 2003-07-16 PT PT03765124T patent/PT1561460E/pt unknown
- 2003-07-16 US US10/521,382 patent/US20060134785A1/en not_active Abandoned
- 2003-07-16 ES ES03765124T patent/ES2279172T3/es not_active Expired - Lifetime
- 2003-07-16 DE DE60310605T patent/DE60310605T2/de not_active Expired - Fee Related
- 2003-07-16 SI SI200330701T patent/SI1561460T1/sl unknown
-
2007
- 2007-03-08 CY CY20071100323T patent/CY1106361T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004009060A1 (es) | 2004-01-29 |
| DE60310605T2 (de) | 2007-09-27 |
| EP1561460A1 (en) | 2005-08-10 |
| PT1561460E (pt) | 2007-03-30 |
| ES2279172T3 (es) | 2007-08-16 |
| CY1106361T1 (el) | 2011-10-12 |
| CA2492995A1 (en) | 2004-01-29 |
| ATE348602T1 (de) | 2007-01-15 |
| US20060134785A1 (en) | 2006-06-22 |
| ES2221530B1 (es) | 2006-02-16 |
| ES2221530A1 (es) | 2004-12-16 |
| EP1561460B1 (en) | 2006-12-20 |
| DE60310605D1 (de) | 2007-02-01 |
| SI1561460T1 (sl) | 2007-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1561460T3 (da) | Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme | |
| ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
| BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
| FR16C0030I1 (fr) | Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
| MY145790A (en) | Composition | |
| CA2481848A1 (en) | Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation | |
| ATE544447T1 (de) | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung | |
| TW200637581A (en) | Anti-caries oral care composition with a chelating agent | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| ATE546135T1 (de) | Hyaluronsäure-nanopartikel | |
| ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| HUP0204546A2 (en) | Carbohydrate formulation for enhancement of immune response | |
| CA2468916A1 (en) | A stable oxaliplatin solution formulation | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| JP2003506416A5 (pt) | ||
| WO2004078105A3 (fr) | Composition de fondaparinux sodique de haute purete | |
| BG108516A (en) | Pharmaceutical formulation | |
| ATE445409T1 (de) | Zusammensetzungen mit matrixproteinen zur regeneration von dentin | |
| MXPA04003506A (es) | Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn. | |
| ATE476195T1 (de) | Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung | |
| MY137570A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon |